Financhill
Back

MaxCyte 10K Form

Sell
38

MXCT
MaxCyte

Last Price:
$2.24
Seasonality Move:
25.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MXCT News And Ratings

See the #1 stock for the next 7 days that we like better than MXCT

MXCT Financial Statistics

Sales & Book Value

Annual Sales: $38.6M
Cash Flow: $-15.1M
Price / Cash Flow: 0
Annual Sales: $1.88
Price / Book: 1.2

Profitability

EPS (TTM): -0.40000
Net Income (TTM): $-41.8M
Gross Margin: $31.5M
Return on Equity: -19.59%
Return on Assets: -17.02%

MaxCyte Earnings Forecast

Key MaxCyte Financial Ratios

  • The Gross Profit Margin over the past 13 years for MXCT is 81.62%.
  • The Selling, General & Administrative Expenses for MXCT have been equal to 145.89% of Gross Profit Margin.
  • The Research & Development expenses have been 57.54% of Revenue.
  • The Net Earning history of MXCT is -106.29% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 4 years.

MaxCyte Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: MXCT
Website: maxcyte.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.23
Quick Ratio: 11.29

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MXCT Technical Analysis vs Fundamental Analysis

Sell
38
MaxCyte (MXCT) is a Sell

Is MaxCyte a Buy or a Sell?

  • MaxCyte stock is rated a Sell
    The current MaxCyte [MXCT] share price is $2.25. The Score for MXCT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.